Comparison of mirabegron and vibegron for clinical efficacy and safety in female patients with overactive bladder: a multicenter prospective randomized crossover trial.

Naoki WadaMitsuhiro MizunagaNoriyuki AbeKotona MiyauchiShin KobayashiMiyu OhtaniRyoken TsunekawaMasaya NagabuchiShun MorishitaTeppei OhyamaSatoshi YamaguchiHiromichi IuchiTsuyoshi NodaYuji SagaTadasu MotoyaNorihiro KawakamiMasayuki NishiharaAtsushi NumataHidehiro Kakizaki

Published in: World journal of urology (2024)

The efficacies of mirabegron and vibegron in female patients was similar. The patients' preference for vibegron could depend on the efficacy of vibegron for urgency incontinence.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
double blind
open label
phase iii
clinical trial
randomized controlled trial
cross sectional
patient reported outcomes